ChatGPT Provides Inaccurate Responses to Questions About Drug Information
Drug Topics
DECEMBER 7, 2023
Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.
Sat.Dec 02, 2023 - Fri.Dec 08, 2023
529 
4 historic FDA approvals from 2023
PharmaVoice
DECEMBER 6, 2023
This year’s many firsts included a vaccine for RSV and a drug that slows Alzheimer’s disease.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Addressing Burnout: Why Psychological Safety Matters at Work
Pharmacy Times
DECEMBER 8, 2023
Psychological safety substantially contributes to team effectiveness, learning, employee retention, and—most critically—better decisions and better performance.
In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
STAT
DECEMBER 8, 2023
The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder. The new medicine , called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Unintended Impact of Opioid Prescribing Guidelines: Part 1
Drug Topics
DECEMBER 5, 2023
The CDC first released opioid prescribing guidelines in 2016.
Transforming blood cancer care to make a difference for patients
PharmaVoice
DECEMBER 4, 2023
AstraZeneca’s Gemma Satterthwaite talks to the company’s ambition to transform the entire care experience for patients with blood cancers.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
New gene therapies confront many sickle cell patients with an impossible choice: a cure or fertility
STAT
DECEMBER 6, 2023
As a teenager, Marie Tornyenu was always having to explain herself. If it wasn’t the chronic absences that had her doing homework from a hospital bed, it was the quilted blanket she carried with her on the days she could attend class. “It was a running joke that I was like 80 years old,” she said. “I would usually just laugh it off because the alternative was too depressing.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
Drug Topics
DECEMBER 7, 2023
A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
The weight loss market looks unstoppable. How high could it go?
PharmaVoice
DECEMBER 4, 2023
Market expectations for obesity drugs are soaring and competition is heating up. But hitting the heights will require overcoming payer and other issues.
Novel Technology Could Reduce Weight Control Drug Injections for Patients With Diabetes
Pharmacy Times
DECEMBER 4, 2023
A new hydrogel drug delivery system could change the way diabetes is managed.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Pfizer plans to depart BIO
STAT
DECEMBER 5, 2023
WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the decision. The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.
Instagram Could Serve as Educational Platform for New FDA Drug Approvals
Drug Topics
DECEMBER 4, 2023
An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.
The FDA is poised to approve the first CRISPR drug. Here’s what’s next in gene editing.
PharmaVoice
DECEMBER 8, 2023
A look at the fast-evolving pipeline for gene editing therapies.
FDA Approves Iptacopan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Adult Patients
Pharmacy Times
DECEMBER 6, 2023
During clinical trials, individuals treated with iptacopan had increased hemoglobin levels and did not need to receive blood transfusions.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: CVS’s new drug payment plan won’t lower patients’ prices, experts warn
STAT
DECEMBER 5, 2023
CVS Health is promising to simplify how its pharmacies get paid for drugs. But that doesn’t mean the drugs will get cheaper. The country’s biggest pharmacy chain said it’s switching to a system where pharmacy benefit managers, employers, and other insurers pay for drugs based on the cost of the drug plus a set markup and dispensing fee.
How Health-System Specialty Pharmacists’ Actions Impact External Pharmacy Patients
Drug Topics
DECEMBER 8, 2023
The analysis revealed deeper issues created by payer and manufacturer lockouts placed on Integrated Health System Specialty Pharmacies.
Real Chemistry’s CEO on biopharma’s outlook in 2024
PharmaVoice
DECEMBER 7, 2023
Shankar Narayanan, CEO of marketing consulting firm Real Chemistry, weighs in on where the industry is headed in the New Year.
FDA Approves Casgevy, Lyfgenia for the Treatment of Sickle Cell Disease
Pharmacy Times
DECEMBER 8, 2023
This FDA approval represents the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years of age and older.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
‘Last roll of the dice’ for a near-term HIV vaccine fails
STAT
DECEMBER 6, 2023
A study billed as the last chance to develop an HIV vaccine this decade has been shut down, investigators announced Wednesday at a conference in Harare, Zimbabwe. The trial, known as PrEPVacc, was testing two different vaccine regimens on about 1,500 volunteers in East and Southern Africa. After multiple other high-profile trials failed , a PrEPVacc investigator described the study this summer as “ the last roll of the dice ” for an HIV vaccine until the 2030s.
Pharmacist-Led Intervention Could Help Lower Rates of Inappropriate Aspirin Use
Drug Topics
DECEMBER 5, 2023
Updated guidance from the United States Preventive Services Task Force advises against low-dose aspirin use as a primary prevention of atherosclerotic cardiovascular disease in certain populations who have bleeding risks.
The fortunes and flops of pharma M&A
PharmaVoice
DECEMBER 4, 2023
Hindsight offers a better perspective on why some deals are fruitful and others fail.
FDA Approves Isavuconazonium Sulfate to Treat Invasive Aspergillosis and Invasive Mucormycotic
Pharmacy Times
DECEMBER 8, 2023
The approval marks isavuconazonium sulfate as the only granted azole antifungal therapy for pediatric individuals AI and IM that are as young as 1 years old.
New England Journal of Medicine reckons with its racist past and complicity in slavery
STAT
DECEMBER 6, 2023
The New England Journal of Medicine, the world’s oldest continually published medical journal, publicly reckoned with its history and complicity surrounding slavery and racism Wednesday, publishing the first of a series of essays by independent historians on the role the prestigious publication has played in perpetuating racist thinking in medicine that continues to this day.
Slideshow: Evaluating Perioperative Opioid Use and Analgesic Options
Drug Topics
DECEMBER 4, 2023
Three poster presented at the ASHP Midyear Clinical Meeting delved deeper into perioperative pain management.
‘It’s not worth risking your life’: fears over painkiller Nolotil grow for Brits in Spain
The Guardian - Pharmaceutical Industry
DECEMBER 2, 2023
Links between the deaths of UK patients and the popular drug have spurred on action among expats in Jávea and beyond As Britain faced widespread frosts last week, there were blue skies, a warm breeze and temperatures above 20C on white sand beaches dotted with palm trees in Jávea on the Costa Blanca. About 5,000 Britons live in this small town, once walled and fortified to protect it from marauding pirates.
Protect Patients During Respiratory Virus Season
Pharmacy Times
DECEMBER 8, 2023
Influenza, COVID-19, and respiratory syncytial virus will all peak in the coming months.
STAT+: J&J to emphasize cancer drugs and stop much of its vaccine research
STAT
DECEMBER 5, 2023
Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease. To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.
Examining Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the Treatment of HBV
Drug Topics
DECEMBER 8, 2023
Two posters presented at ASHP Midyear 2023 looked at how the two medications differed and how clinical pharmacy services improved transitions.
Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
The FDA Law Blog
DECEMBER 4, 2023
By Larry K. Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. On October 10th, based on ability to pay, the U.S. District Court for the Western District of Texas imposed a $275,000 civil penalty on Zarzamora Healthcare LLC, in San Antonio, and its pharmacist-owner.
HIV/AIDS Awareness Month Highlights Opportunities for Pharmacy
Pharmacy Times
DECEMBER 6, 2023
As HIV has become a manageable chronic condition, and even curable in some cases, the role of pharmacists cannot be understated.
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
STAT
DECEMBER 5, 2023
Here are two things that are true. The world needs more effective flu vaccines. And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology.
PDSA System Can Help Pharmacies Comply With USP
Drug Topics
DECEMBER 7, 2023
By identifying areas of improvement and offering recommendations based on a prior cycle, investigators developed a new Plan-Do-Study-Act (PDSA) cycle to meet standards of USP.
Generative AI expected to take off in 2024, but concerns linger over cost, reliability and security
Fierce Healthcare
DECEMBER 6, 2023
Only 25% of healthcare organizations have deployed generative AI solutions. | Only 25% of healthcare organizations have deployed generative AI solutions but that is expected to more than double next year as executives see opportunities to automate clinical documentation and improve patient communication.
Let's personalize your content